Predictive Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell POAI and other ETFs, options, and stocks.About POAI
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate.
CEORaymond F. Vennare
CEORaymond F. Vennare
Employees24
Employees24
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2002
Founded2002
Employees24
Employees24
POAI Key Statistics
Market cap18.53M
Market cap18.53M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume21.71K
Average volume21.71K
High today$5.90
High today$5.90
Low today$5.41
Low today$5.41
Open price$5.80
Open price$5.80
Volume50.42K
Volume50.42K
52 Week high$45.90
52 Week high$45.90
52 Week low$4.76
52 Week low$4.76
Stock Snapshot
With a market cap of 18.53M, Predictive Oncology(POAI) trades at $5.58. The stock has a price-to-earnings ratio of -0.05.
During the trading session on 2025-12-05, Predictive Oncology(POAI) shares reached a daily high of $5.90 and a low of $5.41. At a current price of $5.58, the stock is +3.1% higher than the low and still -5.4% under the high.
Trading activity shows a volume of 50.42K, compared to an average daily volume of 21.71K.
The stock's 52-week range extends from a low of $4.76 to a high of $45.90.
The stock's 52-week range extends from a low of $4.76 to a high of $45.90.
People also own
Based on the portfolios of people who own POAI. This list is generated using Robinhood data, and it’s not a recommendation.